Dr. Stout is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2100 Erwin Rd
Durham, NC 27705Phone+1 919-620-4467Fax+1 919-613-6430
Summary
- My clinical practice focuses on mycobacterial diseases, including tuberculosis and nontuberculous mycobacterial disease. I also see patients with HIV and general infectious disease problems.
My research focuses on the epidemiology, natural history, and treatment of tuberculosis and nontuberculous mycobacterial infections. I am also interested in the impact of HIV infection on mycobacterial infection and disease, and in examining health disparities as they relate to infectious diseases, particularly in immigrant populations.
Education & Training
Duke University HospitalFellowship, Infectious Disease, 2000 - 2002- Duke University HospitalResidency, Internal Medicine, 1996 - 1999
SUNY Upstate Medical UniversityClass of 1996
Certifications & Licensure
NC State Medical License 1997 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment Start of enrollment: 2008 Dec 01
- Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis Start of enrollment: 2012 Oct 01
- Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection Start of enrollment: 2020 Apr 17
Publications & Presentations
PubMed
- Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol.Roberta Monardo, Sana Arif, Aparna Rege, Erin Simon, Leila Ledbetter
Systematic Reviews. 2025-01-22 - Humoral correlate of vaccine-mediated protection from tuberculosis identified in humans and non-human primates.Natasha S Kelkar, Nicholas C Curtis, Timothy P Lahey, Wendy Wieland-Alter, Jason E Stout
Biorxiv. 2024-12-09 - A Balancing Act: Finding the Right Dose of Pyrazinamide to Treat Tuberculosis.Sofia Zavala, Jason E Stout
American Journal of Respiratory and Critical Care Medicine. 2024-12-01
Other
- Tuberculous pericarditisStout J
http://www.uptodate.com/contents/tuberculous-pericarditis
UpToDate, Wolters Kluwer Health - 2012-08-22
Professional Memberships
- Member
- Member
- Fellow
Other Languages
- French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
